MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN method  Kleinkauf N. , Rodloff A.C.   Clinical Microbiology.
Approach to diagnosis of infective endocarditis
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals  Armelle Boisivon,
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
R. Cantón  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Surveillance of Legionnaires’ disease in Austria
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Environmental surveillance and other control measures in the prevention of nosocomial fungal infections  P. Muñoz, A. Burillo, E. Bouza  Clinical Microbiology.
Cryptococcus neoformans var
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Mechanisms of quinolone resistance in clinical isolates of Enterobacter cloacae  Apostolos Georgopoulos, Robert Schein, Astrid Buxbaum, Susan Tzotzos,
Training for the infectious diseases speciality in Norway
Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci.
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton 
Uncommon opportunistic fungi: new nosocomial threats
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
J. Garau  Clinical Microbiology and Infection 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Definition of the Clinical Antibacterial Spectrum of Activity
Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter.
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
Overview of cefixime use in community-acquired infections
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
Modification of prescribers’ behavior: the Icelandic approach
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species†   C.B. Moore,
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.
Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods  C. Muller-Serieys,
Fernando Baquero, John F
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care unit patient surveillance cultures  Rafael Cantón, Nuria Mir, Miguel Sánchez, Fernando Baquero  Clinical Microbiology and Infection  Volume 5, Issue 9, Pages 554-559 (September 1999) DOI: 10.1111/j.1469-0691.1999.tb00434.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Distribution of vancomycin, teicoplanin and LY333328 MIC values for vancomycin-susceptible and -resistant (VanA-type and VanC-type) enterococcal isolates determined using an agar dilution method according to NCCLS guidelines [14]. Clinical Microbiology and Infection 1999 5, 554-559DOI: (10.1111/j.1469-0691.1999.tb00434.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Comparative activity of vancomycin, teicoplanin and LY333328 against 14 vancomycin-susceptible and 30 vancomycin-resistant (21 VanA type, nine VanC type) enterococcal isolates with different inoculum sizes (expressed as fold-dilution change of MIC values). Clinical Microbiology and Infection 1999 5, 554-559DOI: (10.1111/j.1469-0691.1999.tb00434.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.